Skip to main content
. 2023 Apr 18;11:1165125. doi: 10.3389/fcell.2023.1165125

FIGURE 3.

FIGURE 3

Astrocyte morphology is highly affected by the lack of mature NGF in vitro. (A) GFAP-labeled primary astrocytes after a 48 h treatment with NGF, antiV5 (non-relevant control antibody), or αD11 antibody. (B) Sholl analysis of astrocyte morphology (RM One-way ANOVA: p < 0.05; Dunnett’s multiple comparison test; asterisks refer to the comparison between the naive and the treatments at each distance).